REGENERON PHARMACEUTICALS, INC. ($REGN)
Filing Information
| Accession Number | 0001992352-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 3, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
1,200
Total Value
$627,748.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Sep 2, 2026 | Exercise/Conversion | 400 | $719.37 | $287,748.00 | 1,003 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 2, 2026 | Sale | 400 | $850.00 | $340,000.00 | 603 | Direct | โ | View Details | |
Director | Non-Qualified Stock Option (right to buy) | Derivative | Sep 2, 2026 | Exercise/Conversion | 400 | $0.00 | $0.00 | 1,158 | Direct | โ | View Details |